Clinical Trials in Portland

Showing 2181-2200 of 8,670 trials

LTFU for All Cell and Gene Therapy Studies

NCT06194461

Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.

Hepatocellular CarcinomaProstate Cancer

AstraZeneca64 participantsStarted Sep 2025

Phoenix, Arizona, United States • Duarte, California, United States • Orange, California, United States +22 more locations

Active Not RecruitingPhase 3< 1 mile

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

NCT02612454

The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD. The secondary objectives of the study are: * To assess the long-term efficacy of dupilumab in pediatric participants with AD * To assess the trough concentrations of functional dupilumab in serum and the immunogenicity in pediatric participants with AD after re-treatment with dupilumab Optional Pre-filled Pen (PFP) Sub-Study in pediatric patients ≥2 to \<12 years of age with AD Co-Primary Objectives are: * To evaluate the pharmacokinetic (PK) of dupilumab PFPs * To evaluate the safety of dupilumab PFPs Secondary Objective is: \- To evaluate the immunogenicity of dupilumab PFPs

Atopic Dermatitis

Regeneron Pharmaceuticals880 participantsStarted Oct 2015

Birmingham, Alabama, United States • Gilbert, Arizona, United States • Bakersfield, California, United States +81 more locations

LTFU for All Cell and Gene Therapy Studies

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

Find Trials by Condition in Portland

Post-Approval Study of the TREO Abdominal Stent-Graft System

Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome

Can Early Initiation of Rehabilitation With Wearable Sensor Technology Improve Outcomes in mTBI?

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Measurement of Relaxin Peptide in Multiple Sclerosis (MS)

Clinical Investigation of the Next-Generation Intraocular Lenses

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

Cough Reduction in IPF With Nalbuphine ER

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

CAPRI National Juvenile Idiopathic Arthritis Registry

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.